Red Arrow Therapeutics, Co., Ltd. has been recognized as one of the ‘Top 10 Most Promising Biotech Startups from Asia
Red Arrow Therapeutics, Co., Ltd. has been recognized as one of the ‘Top 10 Most Promising Biotech Startups from Asia – 2023’ by Asia Business Outlook magazine in their July issue! This prestigious recognition validates our commitment to innovation and transformative solutions in cancer immunotherapy. Join us in celebrating this milestone achievement!